PBMs

Controversy heats up over pharmacy benefit manager DIR feesPBMs make the argument for DIR fees after a litany of complaints from industry stakeholders.
Top solutions to lower drug pricesPBMs partnering with pharmacies and drug makers may have a solution to nonadherence due to high pharma costs.
Groups praise lawsuit against Walgreens, CVSPharmacy and medical organizations lauded a new class action lawsuit against CVS Health and Walgreens, alleging the two pharmacy chains colluded with pharmacy benefit managers (PBMs) to drive up the cost of generic drugs.
Opinion: Top 2 takeaways from UBS Global Healthcare ConferenceThe conference raised important points about unregulated growth opportunities and new pharmacy arena players.
Four ways PBMs must change to thrive in the future
Four ways PBMs must change to thrive in the futureThe days of the traditional, channel-focused and largely enshrouded PBM business model have come and gone. Here’s what’s next.
Can Amazon change the pharmacy landscape?Industry experts analyze issues of mail delivery and transparency in the prescription drug market.
Why This PBM Comparison Is a Bit of a WhopperAre pharmacies really comparable to fast-food outlets?
Fourteen things Trump needs to know about opioidsAs President Trump promises fight the opioid epidemic, here are 14 things experts want him to know.
Reader Response
Drug Spending Slows for Major Pharmacy Benefit Managers